# Addex Therapeutics Ltd.: Form 20-F for the period ended Dec 31, 2025

- Company: [Addex Therapeutics Ltd.](/companies/adxn.md) (CIK 1574232)
- Form: 20-F
- Filed: 2026-05-15
- Accepted by EDGAR: May 15, 2026, 16:00 ET
- Period: 2025-12-31
- Accession: 0001104659-26-062447
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1574232/000110465926062447/adxn-20251231x20f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1574232/000110465926062447/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2025-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Shares outstanding | at 2025-12-31 | 147,831,814 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1574232/000110465926062447/adxn-20251231x20f.htm

Filed May 15, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-062447. Last ingested by Listed: Oct 29, 2026, 06:06 ET. No prices; not investment advice.